Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management
- 26 July 2022
- journal article
- editorial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 63, 6-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review UpdateDrugs, 2020
- Current Evidence on Abuse and Misuse of GabapentinoidsDrug Safety, 2020
- Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017JAMA, 2018
- How addictive are gabapentin and pregabalin? A systematic reviewEuropean Neuropsychopharmacology, 2017
- Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic useExpert Review of Neurotherapeutics, 2016
- Voltage‐gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacologyThe Journal of Physiology, 2016
- Gabapentin misuse, abuse and diversion: a systematic reviewAddiction, 2016
- Abuse Potential of PregabalinCNS Drugs, 2016
- The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trialsEpilepsia, 2011